Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer. Ko AH. J Clin Oncol 2023;41:3275-3276.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ko AH. Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer. J Clin Oncol 2023;41:3275-3276.
PMID: 37315388